Question 1

What are the potential side effects of AG-013736?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer clinical trial (NCT00389441). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to other options available for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer clinical trial (NCT00389441). Contact the study team or your healthcare provider for specific answers.

Question 3

What does the treatment process involve, and how often will I need to come in for visits?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer clinical trial (NCT00389441). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any specific eligibility criteria I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer clinical trial (NCT00389441). Contact the study team or your healthcare provider for specific answers.

Question 5

How will we monitor the effectiveness of the treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer clinical trial (NCT00389441). Contact the study team or your healthcare provider for specific answers.

What this study is about